Europe's medicines regulator has recommended approving the use of Moderna's Covid vaccine in 12- to 17-year-olds, paving the way for it to become the second shot approved for adolescent use in the European Union.
The use of the vaccine will be the same in adolescents as in people above 18 years, the European Medicines Agency (EMA) said, adding the vaccine produced a comparable antibody response to that seen in 18- to 25-year olds.
Vaccinating children has been considered important for reaching herd immunity against Covid-19 and in light of the highly contagious Delta variant.
In May, Moderna said its vaccine was found to be safe and effective in teenagers. EMA's safety committee said while common side effects in teenagers after vaccination